Sharp Daily
No Result
View All Result
Monday, May 26, 2025
  • Home
  • News
    • Politics
  • Business
    • Banking
  • Investments
  • Technology
  • Startups
  • Real Estate
  • Features
  • Appointments
  • About Us
    • Meet The Team
Sharp Daily
  • Home
  • News
    • Politics
  • Business
    • Banking
  • Investments
  • Technology
  • Startups
  • Real Estate
  • Features
  • Appointments
  • About Us
    • Meet The Team
No Result
View All Result
Sharp Daily
No Result
View All Result
Home Healthcare

PPB and ACA sign MoU to combat counterfeit medicine

Brenda Murungi by Brenda Murungi
January 17, 2024
in Healthcare, News
Reading Time: 2 mins read

The Anti-Counterfeit Authority (ACA) and the Pharmacy and Poisons Board (PPB) have entered into a Memorandum of Understanding (MoU) amid an escalating threat to public safety from the increasing influx of counterfeit pharmaceutical products.

ACA identifies emergency contraception, malaria drugs, and beauty products as the most frequently counterfeited items in the country. The Authority acknowledges that illicit trade in Kenya exceeded KES 1 trillion by 2023, with counterfeit trade contributing between KES 80 billion and KES 100 billion to this total.

The MoU aims to strengthen oversight and enforce the rights of health product and technology owners. Its primary focus is preventing the distribution of counterfeit health products within Kenya’s borders.

The agreement establishes a comprehensive framework that includes elements such as information exchange, collaborative investigations, capacity building, research, regulatory alignment, and consistent communication among the involved agencies.

RELATEDPOSTS

Deadly human-wildlife conflict in Nairobi and Nyeri

April 22, 2025

Pharmacy board clears Mefenamic Acid suspension for market distribution

March 18, 2025

Counterfeit product prevalence in Kenya is largely attributed to porous borders, with 80 percent of fake goods entering from neighboring countries. The Pharmacy and Poisons Board (PPB) notes that its ability to control the influx of counterfeit pharmaceutical products is hindered by insufficient resources.

PPB CEO Dr. Fred Siyoi highlights challenges posed by advancements in technology, such as AI and social media platforms like TikTok, where unauthorized advertisements for medicine may proliferate beyond regulatory control. He emphasizes the difficulty in managing platforms like TikTok and other emerging channels due to limited resources.

Dr. Njoroge underscores the importance of recording intellectual property rights and collaborating with various government agencies to combat the growing menace of counterfeit trade in the country.

Previous Post

NIBS founder Lizzie Wanyoike set to be buried next Tuesday

Next Post

Heri Holdings acquires Nova Academies’ property arm with regulator’s nod

Brenda Murungi

Brenda Murungi

Related Posts

News

Co-op Bank posts KES 6.9 billion profit in Q1’2025

May 16, 2025
Agriculture And Economy
News

Lets get Kenya out of FATF list

May 9, 2025
News

The downside of Impact Investing

May 2, 2025
Analysis

Kisumu airport to become Kenya’s agro-export powerhouse

April 30, 2025
Healthcare

Health CS Duale launches probe into organ transplant practices

April 25, 2025
News

Leadership challenges at the University of Nairobi

April 24, 2025

LATEST STORIES

The Green Season Secret

May 23, 2025

Restructure housing levy to solve Kenya’s housing crisis

May 23, 2025
NCBA Bank

NCBA group records 3.4% profit growth in Q’1 2025

May 23, 2025

The rise of satellite towns: Redefining urban growth in Kenya

May 23, 2025

Concerns grow over Kenya’s duty-free trade deal with the U.S.

May 22, 2025

Lessons from Equity Bank’s M-Pesa scandal

May 22, 2025

SACCO’s at the heart of rural financial inclusion in Kenya

May 22, 2025

Kenya’s insurance sector in 2025

May 22, 2025
  • About Us
  • Meet The Team
  • Careers
  • Privacy Policy
  • Terms and Conditions
Email us: editor@thesharpdaily.com

Sharp Daily © 2024

No Result
View All Result
  • Home
  • News
    • Politics
  • Business
    • Banking
  • Investments
  • Technology
  • Startups
  • Real Estate
  • Features
  • Appointments
  • About Us
    • Meet The Team

Sharp Daily © 2024